Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: A Study of ALS-008176 in Infants Hospitalized With RSV [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating ALS-008176 in infants hospitalized with Respiratory Syncytial Virus infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALS-008176

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED